Information about Ns Pharma
My details
*
*
*

Ns Pharma (SRL)

BE 0822.653.238

Rue D'auvelais(ARS) 43/B, 5060 Sambreville

Company information

Status
Active

Enterprise number

BE0822.653.238

VAT liability
Yes
Established
27-01-2010
Last balance sheet year
2025
Company size
Small 1,2 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Ns Pharma

2025 2024 2023 2022
Profit/Loss € 35,970 -15 % € 42,261 -24 % € 55,753 21 % € 46,089
Equity € 269,360 10 % € 244,335 21 % € 202,074 26 % € 159,821
Gross margin € 215,691 -6 % € 229,875 -8 % € 250,909 4 % € 240,794
Employees 1.2 1.2

Publications from Ns Pharma

Date Publication
20-12-2023 Modification Legal Form - Resignations, Appointments (FR)
10-05-2010 Miscellaneous (FR)
08-02-2010 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Ns Pharma?
The VAT number of Ns Pharma is BE 0822.653.238.
Wat is the PEPPOL ID of Ns Pharma?
The PEPPOL ID of Ns Pharma is 0208:0822653238. Log in or start a free trial to see the full overview.
When was Ns Pharma founded?
Ns Pharma was founded on 27-01-2010.
What is the address of Ns Pharma?
The current registered office of Ns Pharma is located at Rue D'auvelais(ARS) 43/B, 5060 Sambreville.
When was the last time Ns Pharma filed their annual financial statements?
The most recent financial statements of Ns Pharma were filed on 07-02-2026.
How many employees does Ns Pharma have?
There are 1,2 FTEs working at Ns Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Ns Pharma?
At the time of its most recent financial statements, Ns Pharma did not publish any turnover figures. Ns Pharma reported a gross margin of €215,690.55.

Sources